IL173435A0 - Bicyclo '3.1.1 heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors - Google Patents

Bicyclo '3.1.1 heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Info

Publication number
IL173435A0
IL173435A0 IL173435A IL17343506A IL173435A0 IL 173435 A0 IL173435 A0 IL 173435A0 IL 173435 A IL173435 A IL 173435A IL 17343506 A IL17343506 A IL 17343506A IL 173435 A0 IL173435 A0 IL 173435A0
Authority
IL
Israel
Prior art keywords
bicyclo
agonists
quinazolinone derivatives
orl1 receptors
human orl1
Prior art date
Application number
IL173435A
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2004/052392 external-priority patent/WO2005032547A1/en
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL173435A0 publication Critical patent/IL173435A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL173435A 2003-10-03 2006-01-30 Bicyclo '3.1.1 heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors IL173435A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50794703P 2003-10-03 2003-10-03
EP03103671 2003-10-03
PCT/EP2004/052392 WO2005032547A1 (en) 2003-10-03 2004-10-01 Bicyclo`3.1.1!heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Publications (1)

Publication Number Publication Date
IL173435A0 true IL173435A0 (en) 2006-06-11

Family

ID=34424772

Family Applications (1)

Application Number Title Priority Date Filing Date
IL173435A IL173435A0 (en) 2003-10-03 2006-01-30 Bicyclo '3.1.1 heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors

Country Status (3)

Country Link
KR (1) KR20060134927A (en)
IL (1) IL173435A0 (en)
NO (1) NO20061966L (en)

Also Published As

Publication number Publication date
NO20061966L (en) 2006-06-29
KR20060134927A (en) 2006-12-28

Similar Documents

Publication Publication Date Title
ZA200604791B (en) Hydronopol derivatives as agonists on human ORL1 receptors
ZA200409333B (en) 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors.
AU2003238597A8 (en) Benzimidazole compounds and their use as estrogen agonists/antagonists
AU2003223579A8 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
PL377215A1 (en) Benzimidazole derivatives and their use as vanilloid receptor ligands
IL159025A0 (en) Hydrophobic dopamine agonists administered to the dermis
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
IL175544A0 (en) The use of n-arylhydrazine derivatives for combating pests in and on animals
PL377296A1 (en) 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
IL166100A0 (en) 7,8,9-10-tetrahydro-6h-azepino,6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrroloÄ2,1-bÜ quinazolinone derivatives
HK1079518A1 (en) Quinazolinone derivatives and their use as cb agonists
AR025883A1 (en) USE OF ANTAGONISTS OF THE CENTRAL CANNABINOID RECEPTORS FOR THE PREPARATION OF MEDICINES
MXPA03006524A (en) Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands.
AU2003263068A8 (en) Sanitary sleeve or tip for intra-oral three-dimensional camera
DK1463759T3 (en) Ligand for the G-protein-coupled receptor GPR43 and uses thereof
AU2003268413A8 (en) Device with agent using preprocessing update techniques
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
ZA200308147B (en) Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals.
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
AU2003284885A8 (en) Device and methods for sequential, regional delivery of multiple cytotoxic agents
SI1532141T1 (en) 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS
IL173435A0 (en) Bicyclo '3.1.1 heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
IL165942A0 (en) Acyloxypyrrolidine derivatives and use thereof as ligands of vib or both vib and via receptors
MXPA03001609A (en) Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors.